Cargando…
Role of long non-coding RNA H19 in therapy resistance of digestive system cancers
Digestive system cancers are associated with high morbidity and mortality. Chemotherapy and radiotherapy are the main treatment modalities for these cancers. However, the development of therapy resistance leads to high rates of tumor recurrence and metastasis, resulting in dismal prognosis. Long non...
Autores principales: | Wang, Jingting, Ma, Xiao, Si, Hai, Ma, Zhongjun, Ma, Yan, Wang, Jing, Cao, Bangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786989/ https://www.ncbi.nlm.nih.gov/pubmed/33402118 http://dx.doi.org/10.1186/s10020-020-00255-2 |
Ejemplares similares
-
Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
por: Wang, Jingting, et al.
Publicado: (2022) -
Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer
por: Wang, Jing, et al.
Publicado: (2020) -
Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis
por: Ma, Yan, et al.
Publicado: (2022) -
Exosomes derived from 5-fluorouracil-resistant colon cancer cells are enriched in GDF15 and can promote angiogenesis
por: Zheng, Xixi, et al.
Publicado: (2020) -
Safety and efficacy of spleen aminopeptide oral lyophilized powder for improving quality of life and immune response in patients with advanced breast cancer: a multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Wang, Jing, et al.
Publicado: (2021)